newsfilter
← Latest News
GlobeNewswire·

Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

MALVERN, Pa., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (NASDAQ:GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary